[Webinar] Designing an mRNA process development platform: a quality by design approach

mRNA is opening up new ways to prevent, treat and possibly cure debilitating diseases, but as with any new therapeutic modality, the bench to bedside journey comes with uncertainties. Samsung Biologics stands ready to develop, characterize, validate and transfer your technology from any stage of development, offering a one-stop solution to facilitate your path to commercial. Check out this speaking session where @Eunseo Lee, Lead Manager in mRNA Manufacturing, presents on our mRNA platforms for next generation therapeutics, from concept to clinical validation and commercialization. [LINK] #samsungbiologics #cdmo #cdo #mRNA #innovation #biopharma 00:00 Intro 00:03 Opening 00:22 mRNA-based Therapeutics Challenges 01:59 Technical Liaison for Developers’ Longer Journey 03:54 Manufacturing Flexibility 05:53 RNA Molecular Engineering Development 07:07 RNA Process Development Platform Based on QbD 09:01 List of Critical Quality Attributes 10:06 Process Parameters 11:11 Case Study: mRNA-LNP Lyophilization DoE 12:02 mRNA-LNP Lyophilization - Screening 14:27 mRNA-LNP Lyophilization - Oprimization 15:36 Samsung Biologics mRNA Manufacturing Capabilities 16:25 Samsung Biologics mRNA Proprietary Technology 17:17 Your first-choice mRNA CDMO partner